SCHEMBL6652259

SCHEMBL6652259

C/C(O)=C(/C#N)C(=O)Nc1ccc(Cl)c(Cl)c1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 12/20 0.72
GAA P10253 2/20 0.53
MEN1 O00255 3/20 0.52
ALDH1A1 P00352 3/20 0.52
KMT2A Q03164 3/20 0.52
POLB P06746 1/20 0.52
EPHX1 P07099 1/20 0.51
EPHX2 P34913 1/20 0.51
CYP3A4 P08684 2/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2C9 P11712 1/20 0.50
PKM P14618 1/20 0.50
ALOX15 P16050 1/20 0.50
TSHR P16473 1/20 0.50
LMNA P02545 1/20 0.50
THRB P10828 1/20 0.50
BLM P54132 1/20 0.50
BTK Q06187 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
PLK3 Q9H4B4 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6652261 1.00 DHODH (0.72) DHODHGAAMEN1ALDH1A1KMT2A
SCHEMBL8714895 0.89 DHODH (0.69) DHODHGAAMEN1ALDH1A1KMT2A
SCHEMBL8714900 0.89 DHODH (0.69) DHODHGAAMEN1ALDH1A1KMT2A
SCHEMBL8810580 0.87 DHODH (0.67) DHODHGAAMEN1ALDH1A1KMT2A
SCHEMBL9092492 0.87 DHODH (0.67) DHODHGAAMEN1ALDH1A1KMT2A
SCHEMBL9182276 0.86 DHODH (0.56) DHODHGAAMEN1ALDH1A1KMT2A
SCHEMBL9182280 0.86 DHODH (0.56) DHODHGAAMEN1ALDH1A1KMT2A
SCHEMBL23752183 0.84 DHODH (1.00) DHODHGAAMEN1ALDH1A1KMT2A
SCHEMBL5914887 0.83 DHODH (0.70) DHODHGAAMEN1ALDH1A1KMT2A
SCHEMBL5914889 0.83 DHODH (0.70) DHODHGAAMEN1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1071658-B1 BTK INHIBITORS AND METHODS FOR THEIR IDENTIFICATION AND USE PARKER HUGHES INST (US) 2004-06-16 EP disclosed
US-6365626-B1 LEFLUNOMIDE METABOLITE ANALOGS FOR TREATING IMPROPER PLATELET AGGREGATION; LEUKEMIA; LYMPHOMAS PARKER HUGHES INSTITUTE 2002-04-02 US disclosed